Viewing Study NCT06413641



Ignite Creation Date: 2024-05-19 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06413641
Status: RECRUITING
Last Update Posted: 2024-05-14
First Post: 2024-04-12

Brief Title: VIsualization of Coronary Artery Disease for Modification of RISK Factors
Sponsor: Aarhus University Hospital
Organization: Aarhus University Hospital

Study Overview

Official Title: VIsualization of Coronary Artery Disease for Modification of RISK Factors Prevention of Disease Progression in Patients With Non-Obstructive Coronary Atherosclerosis
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VICAD-RISK
Brief Summary: The VICAD-RISK study assesses if visualization of coronary CT angiography images in participants with non-obstructive coronary artery disease will improve LDL lowering reduce reporting of side effects by cholesterol lowering medications and modify the coronary artery disease phenotype over 12 months
Detailed Description: In Denmark non-obstructive coronary artery disease is found in 35-40 of patients undergoing coronary CT angiography for suspected coronary artery disease Modification of risk factors is essential in patients with coronary artery disease to prevent major cardiovascular events However in non-obstructive coronary artery disease initiation and adherence to treatment with lipid lowering therapy is poor

The study will include 390 patients from 5 different sites patients will be randomized into 3 groups standard follow up by general practice structured disease education or the combination of the latter with visualization of coronary CT angiography images A follow-up CT angiography will be performed at 12 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
1-10-72-213-22 OTHER VMK NVK None